#SFHS2609033AOrder of April 8, 2026 Deregistering Pharmaceutical Specialties from the List of Medicines Approved for Public Collections
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law removes a specific pharmaceutical product, PHEBURANE 350 mg/ml, from the list of medicines approved for use by public communities in France. This impacts healthcare providers and public health institutions who may need to adjust their inventories and future orders.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Removal of PHEBURANE 350 mg/ml from approved medicines list
Obligations
What this law requires
Remove PHEBURANE 350 mg/ml, solution buvable (flacon verre 100 ml, boîte de 1 flacon + 1 seringue de dosage avec adaptateur pour flacon, CIP: 34009 303 213 5 5) from the list of approved medicines for public collections
Cease procurement and distribution of PHEBURANE 350 mg/ml (laboratoires LUCANE PHARMA, CIP: 34009 303 213 5 5) through public health systems following the effective date of this order
Update inventory management systems and approved medicine databases to reflect the deregistration of PHEBURANE 350 mg/ml
Publish this order in the Journal officiel de la République française